BA
GILD icon

Bivin & Associates’s Gilead Sciences GILD Stock Holding History

Bivin & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1K Hold
10
– – ﹤0.01% 267
2022
Q1 		$1K Hold
10
– – ﹤0.01% 295
2021
Q4 		$1K Buy
+10
New +$689 ﹤0.01% 310

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bivin & Associates's GILD Position: Q2 2022 in Review

Bivin & Associates held its Gilead Sciences (GILD) position steady in Q2 2022 at 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Bivin & Associates first reported a position in GILD in Q4 2021 and has held it in 3 quarters since. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Bivin & Associates held 10 shares of Gilead Sciences worth $1K as of Q2 2022.
  • Bivin & Associates left its Gilead Sciences share count unchanged in Q2 2022.
  • Gilead Sciences made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #267 holding.
  • Bivin & Associates first reported a position in Gilead Sciences in Q4 2021 and has held it in 3 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.